Holen Sie sich die Stockscreener-App
0.2508
1.07%
-0.0027
Vorhandelsmarkt:
.25
-0.0008
-0.32%
Schlusskurs vom Vortag:
$0.2535
Offen:
$0.2536
24-Stunden-Volumen:
273.55K
Relative Volume:
0.60
Marktkapitalisierung:
$1.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.35M
KGV:
-0.5452
EPS:
-0.46
Netto-Cashflow:
$-5.48M
1W Leistung:
-17.77%
1M Leistung:
-40.46%
6M Leistung:
-80.56%
1J Leistung:
-35.03%
1-Tages-Spanne:
$0.2326
$0.26
1-Wochen-Bereich:
$0.23
$0.30
52-Wochen-Spanne:
$0.23
$3.30
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Firmenname
Shuttle Pharmaceuticals Holdings Inc
Sektor
Telefon
(240) 403-4212
Adresse
401 PROFESSIONAL DRIVE, GAITHERSBURG
Vergleichen Sie SHPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
0.2508 | 1.91M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
146.85 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.19 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.31 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.25 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Shuttle Pharmaceuticals Holdings Inc Aktie (SHPH) Neueste Nachrichten
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - GlobeNewswire
Shuttle Pharma's Latest Glioblastoma Trial Data and Cancer Diagnostic Advances: Key Updates Coming April 23 - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World
Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer - marketscreener.com
Shuttle Pharma files patent for cancer treatment innovation - Investing.com Australia
Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer - marketscreener.com
Shuttle Pharma Developing Pretreatment Diagnostic Blood - GlobeNewswire
Game-Changing Prostate Cancer Treatment: Shuttle Pharma Unveils Breakthrough PSMA Technology - Stock Titan
Head to Head Analysis: Shuttle Pharmaceuticals (NASDAQ:SHPH) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Shuttle Pharmaceuticals Appoints New Interim CEO and CSO - TipRanks
Shuttle Pharmaceuticals signs consulting deal with Bowery Group By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals signs consulting deal with Bowery Group - Investing.com
Shuttle Pharmaceuticals Holdings IncOn March 21, Enters Consulting Agreement With Bowery ConsultingSEC Filing - Marketscreener.com
Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead - Asianet Newsable
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 3.8% – Should You Buy? - Defense World
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SHPH stock touches 52-week low at $0.34 amid market challenges - Investing.com
SHPH stock touches 52-week low at $0.34 amid market challenges By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
SHPHSHUTTLE PHARMACTCLS HLDGS INC Latest Stock News & Market Updates - Stock Titan
Shuttle Pharma Announces Closing Of $5.75 Million Underwritten Offering -March 13, 2025 at 05:39 pm EDT - Marketscreener.com
Shuttle Pharma Secures $5.2M in Public Offering - TipRanks
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - GlobeNewswire
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - Benzinga
Shuttle Pharma Raises $5.75M: Strategic Boost for Revolutionary Cancer Treatment Trial - StockTitan
Shuttle Pharma appoints new interim co-CEO By Investing.com - Investing.com Australia
This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO. - The Business Journals
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Shuttle Pharma announces $5.75 million stock offering - Investing.com India
Shuttle Pharma announces $5.75 million stock offering By Investing.com - Investing.com Canada
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering -March 12, 2025 at 09:25 am EDT - Marketscreener.com
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering - GlobeNewswire
Shuttle Pharma Secures Critical $5.75M Funding for Revolutionary Cancer Radiation Therapy - StockTitan
4 Artificial Intelligence (AI) Stocks Worth Buying in the Tech Sell-Off - The Globe and Mail
Lucid Group (LCID) Prepares to Sink Into Penny Stock Territory - The Globe and Mail
1 Large-Cap Stock with Solid Fundamentals and 2 to Avoid - The Globe and Mail
Shuttle Pharma appoints new interim co-CEO - Investing.com
Shuttle Pharma Appoints Christopher Cooper as Interim Co-CEO - citybiz
Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO - TipRanks
Shuttle Pharma Announces Appointment Of Christopher Cooper As Interim Co-CEO To Enhance Business Activities - Marketscreener.com
Shuttle Pharmaceuticals Appoints Christopher Cooper as Co-CEO - TipRanks
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities - GlobeNewswire
2 Reasons to Watch GE and 1 to Stay Cautious - The Globe and Mail
SHPH stock touches 52-week low at $0.5 amid sharp annual decline - Investing.com Australia
SHPH stock touches 52-week low at $0.5 amid sharp annual decline By Investing.com - Investing.com South Africa
Finanzdaten der Shuttle Pharmaceuticals Holdings Inc-Aktie (SHPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):